NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)

The NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required) is administered by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, which operates under the U.S. Department of Health and Human Services as part of the National Institutes of Health. The program is designed to support small-scale research projects that align with NICHD’s mission areas, including human development, reproductive health, pediatric health, and rehabilitation medicine. This funding opportunity specifically focuses on basic experimental studies involving human participants that also meet the NIH definition of a clinical trial, emphasizing fundamental research rather than applied or product-driven outcomes. The purpose of this grant is to provide limited funding for discrete, well-defined projects that can be completed within a short time frame. The program encourages applications that prospectively assign human participants to experimental conditions and evaluate biomedical or behavioral outcomes to advance understanding of fundamental scientific phenomena. Eligible research may include pilot studies, feasibility studies, secondary data analysis, development of research methodologies, and early-stage technology development, provided that these efforts align with NICHD’s scientific priorities and divisions. Funding under this opportunity is structured as a small grant mechanism with a maximum of 50000 dollars in direct costs per year and a project period of up to two years. This results in a potential total award ceiling of 100000 dollars over the full project period. The funding is intended to support modest research efforts and does not require cost sharing or matching funds. Allowable costs must comply with NIH grants policy, and recipients are expected to adhere to all federal regulations, including data management and sharing requirements. Eligibility for this opportunity is broad and inclusive, encompassing higher education institutions, nonprofit organizations, for-profit entities, government agencies at multiple levels, tribal organizations, and foreign institutions. Individuals with the necessary expertise may serve as principal investigators through an eligible organization. Applicants must complete required registrations, including SAM, Grants.gov, and eRA Commons, prior to submission. Multiple applications are permitted as long as they are scientifically distinct. The application process requires submission through Grants.gov or NIH systems such as ASSIST or institutional system-to-system solutions. Applicants must follow the Research Instructions in the NIH Application Guide and include required components such as a research plan, budget, human subjects documentation, and data management plan. Applications must propose studies that meet both the NIH definition of a clinical trial and basic research. Noncompliant or incomplete applications may be rejected without review. Applications are evaluated through NIH’s peer review process based on criteria including significance, innovation, rigor, feasibility, investigator expertise, and institutional environment. Additional considerations include protections for human subjects, inclusion plans, and data integrity. Following peer review, applications may undergo a second level of review by the advisory council, with funding decisions based on merit, alignment with program priorities, and availability of funds. This funding opportunity follows a recurring submission schedule with multiple standard NIH due dates each year. The current cycle includes a closing date of May 24, 2026, with additional cycles continuing through January 2028 under the original schedule. Applicants are encouraged to submit early and ensure compliance with all submission requirements. Awards are issued following review cycles, with earliest start dates typically occurring several months after submission. Program and administrative contacts are available through NIH for applicant support throughout the process.

Ensure strong alignment with NICHD priorities; emphasize rigor and feasibility; clearly justify study design and sample size; demonstrate investigator capability and institutional support